Melatonin withdrawal

Pro Research Analysisby

Searched over 200M research papers for "melatonin withdrawal"

Analyzed relevant papers

Melatonin Withdrawal: Insights from Recent Research

Introduction to Melatonin and Benzodiazepine Withdrawal

Melatonin, a hormone regulating sleep-wake cycles, has been explored as a potential aid in the withdrawal from benzodiazepines (BZDs) and other sedatives. This article synthesizes findings from multiple studies on the efficacy of melatonin in facilitating withdrawal and its impact on cognitive and psychosocial outcomes.

Efficacy of Melatonin in Benzodiazepine Withdrawal

Short-Term and Long-Term Withdrawal Outcomes

Research indicates that melatonin may not significantly enhance benzodiazepine withdrawal outcomes compared to placebo. A study involving older patients with primary insomnia found that both melatonin and placebo groups achieved high short-term BZD abstinence, but melatonin did not offer additional benefits over placebo in the long term . Similarly, in patients with schizophrenia or bipolar disorder, melatonin did not significantly affect the mean benzodiazepine dosage or cessation rates after 24 weeks of treatment .

Cognitive and Psychosocial Functioning

The impact of melatonin on cognitive performance and psychosocial functioning during benzodiazepine withdrawal has also been investigated. In a study with patients suffering from schizophrenia or bipolar disorder, cognitive performance improved with benzodiazepine dose reduction, but melatonin did not provide additional cognitive benefits . Furthermore, neither melatonin nor benzodiazepine withdrawal significantly affected subjective well-being or psychosocial functioning .

Melatonin's Role in Sleep Quality During Withdrawal

Objective and Subjective Sleep Quality

Melatonin has shown some efficacy in improving subjective sleep quality during benzodiazepine withdrawal. In a study with patients undergoing methadone maintenance treatment, melatonin improved sleep quality, particularly in those who did not completely discontinue benzodiazepine use . However, objective measures of sleep efficiency did not show significant improvement with melatonin .

Differential Receptor Modulation

Melatonin's effects on sleep and withdrawal symptoms may be partly due to its differential modulation of melatonin receptors. Research has shown that melatonin can increase the expression of hMT1 receptors upon withdrawal, which may influence its efficacy in sleep regulation .

Melatonin in Other Substance Withdrawal Contexts

Nicotine Withdrawal

Melatonin has also been studied in the context of nicotine withdrawal. A study found that melatonin significantly reduced negative mood symptoms and cigarette cravings during acute nicotine withdrawal, suggesting its potential utility in managing withdrawal symptoms beyond benzodiazepines .

Methamphetamine Withdrawal

In the case of methamphetamine withdrawal, melatonin treatment during the withdrawal period enhanced cognitive recovery and mitigated neurotoxic effects, indicating its broader neuroprotective properties .

Conclusion

While melatonin shows promise in improving subjective sleep quality and mitigating some withdrawal symptoms, its overall efficacy in facilitating benzodiazepine withdrawal remains comparable to placebo. Further research is needed to fully understand its role and optimize its use in withdrawal management across different substances.

Sources and full results

Most relevant research papers on this topic

Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial.

Gradual dose reduction of BZDs combined with psychosocial support effectively produced high short-term and moderate long-term BZD abstinence, but melatonin showed no withdrawal benefit compared to placebo.

RCTRigorous Journal

2014·

48citations

·R. Lähteenmäki et al.

British journal of clinical pharmacology·

DOI

Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo

Add-on melatonin does not significantly affect cognitive performance, well-being, or psychosocial functioning in patients with severe mental illness after benzodiazepine withdrawal.

RCTRigorous Journal

2017·

45citations

·L. Baandrup et al.

European Archives of Psychiatry and Clinical Neuroscience·

DOI

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder: A randomised, placebo-controlled, blinded trial

Prolonged-release melatonin did not significantly facilitate benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder after 24 weeks of guided gradual dose reduction.

RCT

2016·

41citations

·L. Baandrup et al.

The World Journal of Biological Psychiatry·

DOI

Melatonin differentially modulates the expression and function of the hMT1 and hMT2 melatonin receptors upon prolonged withdrawal.

Melatonin differentially regulates the expression of its own receptors, potentially impacting the transduction of dark signals in vivo.

In Vitro Study

2003·

21citations

·M. Masana et al.

Biochemical pharmacology·

DOI

Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans.

Melatonin treatment significantly reduces the negative mood effects of nicotine withdrawal, helping to counteract the acute effects of smoking cessation on mood.

2000·

38citations

·I. Zhdanova et al.

Pharmacology, biochemistry, and behavior·

DOI

Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial.

Melatonin improves sleep quality during benzodiazepine withdrawal, especially in patients who continue abusing the drug.

RCT

2007·

43citations

·E. Peles et al.

Addiction·

DOI

Objective and subjective sleep quality: Melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use.

Prolonged-release melatonin improves self-reported sleep quality in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use, but does not affect objective sleep efficiency.

RCTRigorous Journal

2016·

40citations

·L. Baandrup et al.

Psychiatry research·

DOI

Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review.

Melatonin and melatonin agonists effectively improve the rate of benzodiazepine and hypnotic discontinuation in patients with primary insomnia.

Systematic Review

2020·

21citations

·A. Morera-Fumero et al.

Drug and alcohol dependence·

DOI

Proteomic Analysis Reveals the Neurotoxic Effects of Chronic Methamphetamine Self-Administration-Induced Cognitive Impairments and the Role of Melatonin-Enhanced Restorative Process during Methamphetamine Withdrawal

Chronic methamphetamine self-administration leads to cognitive impairments in mice, and melatonin treatment during withdrawal can enhance recovery of neurological impairments.

Non-RCTAnimal Study

2023·

9citations

·Tanthai Polvat et al.

Journal of Proteome Research·

DOI

Effects of exogenous melatonin administration and withdrawal in five patients with rapid-cycling bipolar disorder.

Melatonin administration had no significant effects on mood or sleep in rapid-cycling bipolar disorder patients, but withdrawal delayed sleep onset time and may have mild mood-elevating effects.

Highly Cited

1997·

78citations

·Ellen Leibenluft et al.

The Journal of clinical psychiatry·

DOI

Try another search

vitamin b12 metabolism

prenatal vitamins ingredients

b complex for hair growth

metformin increase blood sugar

what exercise lowers blood sugar the fastest

how much protein is in collagen